Theravance Biopharma
is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases... Read moreTheravance Biopharma
is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases... Read more
1996
PublicIndependent CompanyNASDAQTBPH
News
Mar 27, 2025
PR Newswire
Press Release: Theravance Biopharma : Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology
Mar 10, 2025
Seeking Alpha
Theravance Biopharma: Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
Mar 07, 2025
Owler
Theravance Biopharma, Inc.: Theravance Biopharma's employee count changed from 99 in Dec 2023 to 97 in Dec 2024
Feb 28, 2025
Yahoo
Theravance Biopharma: Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Feb 27, 2025
Zacks
Theravance Biopharma: Theravance's Q4 Loss In Line With Estimates, Sales Beat
Feb 12, 2025
StreetInsider
Press Release: Theravance Biopharma : Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Dec 17, 2024
centralcharts
Press Release: Theravance Biopharma : Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Nov 14, 2024
Owler
Theravance Biopharma, Inc.: Theravance Biopharma's revenue changed from $62.02M in Jun 2024 to $63.19M in Sep 2024
Nov 13, 2024
Zacks
Theravance Biopharma: Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
Oct 18, 2024
StreetInsider
Press Release: Theravance Biopharma : Theravance Announces Publication of YUPELRI (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
Theravance Biopharma Competitors
1
2
3
4
5
6
7
8
9
10